The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration
about
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivativeFocused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.Functions of S100 proteins.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Therapeutic potential of cell-penetrating peptides.Designing protein-based biomaterials for medical applications.Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies.Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.Challenges and new strategies for therapeutic peptide delivery to the CNS.Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP[V5G3A2-150].White matter damage after traumatic brain injury: A role for damage associated molecular patterns.Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis.The design and delivery of a PKA inhibitory polypeptide to treat SCA1.Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide.
P2860
Q27319831-735D7809-F4F4-49A5-84F3-4EB0640A1161Q34291585-1FB80409-0518-471F-A442-9A3771F90A61Q35188379-C987222E-F35E-4062-B5EF-DD8A6F7545D1Q37001259-AF8972FC-1879-4A13-BEEE-078F50F9D789Q38096444-A1CE4337-8434-4D8B-8D18-D800397CB97EQ38104407-2A0D8FFA-9B82-4F69-BDAE-96C9906B2C54Q38152205-4AC4500E-AEEC-4687-81B1-952032632760Q38198590-B5F9968C-0439-4A72-B589-725DAE4EBC1EQ38214156-C69DDE05-A654-4957-884C-A89BE36931FBQ38262399-38E57E8F-E3BA-468D-87CB-2D6FEFA17057Q38263314-084973BD-FBA3-48BE-9A76-1F62A42471DEQ38558102-B99B352B-0AE6-4566-A210-0B4517B7C192Q38732841-07205FA5-E505-427A-8B2C-7BD0B3A233DBQ39323255-B15CF771-4972-4A33-BB8F-CE530340ACD5Q41871282-E02C742C-7604-4C7C-B35F-B898EB4A190DQ43523795-4A2D9A35-9ED7-482E-BB61-93EF9FC85D94Q55039164-44463CD5-0880-4FB4-9B6F-B12BA0BCC470
P2860
The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The design and delivery of a t ...... 00B-mediated neurodegeneration
@ast
The design and delivery of a t ...... 00B-mediated neurodegeneration
@en
type
label
The design and delivery of a t ...... 00B-mediated neurodegeneration
@ast
The design and delivery of a t ...... 00B-mediated neurodegeneration
@en
prefLabel
The design and delivery of a t ...... 00B-mediated neurodegeneration
@ast
The design and delivery of a t ...... 00B-mediated neurodegeneration
@en
P2093
P2860
P1433
P1476
The design and delivery of a t ...... 00B-mediated neurodegeneration
@en
P2093
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2011.09.025
P407
P577
2011-09-17T00:00:00Z